4//SEC Filing
Reumuth Mary 4
Accession 0001415889-25-018320
CIK 0001479419other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 8:00 PM ET
Size
5.6 KB
Accession
0001415889-25-018320
Insider Transaction Report
Form 4
KALA BIO, Inc.KALA
Reumuth Mary
CHIEF FINANCIAL OFFICER
Transactions
- Sale
Common Stock
2025-06-24$4.01/sh−3,631$14,560→ 62,100 total
Footnotes (3)
- [F1]This sale was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 9, 2020 to cover tax withholding obligations in connection with the vesting and settlement of the Reporting Person's restricted stock units ("RSUs") granted on June 22, 2023.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.87 to $4.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- [F3]Includes 28,906 unvested RSUs.
Documents
Issuer
KALA BIO, Inc.
CIK 0001479419
Entity typeother
Related Parties
1- filerCIK 0001710969
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 8:00 PM ET
- Size
- 5.6 KB